To verify whether lurbinectedin might trigger apoptosis in SCLC as suggested by the abrogation of the BCL2 apoptosis regulator, we analyzed the apoptotic rate of DMS‐53 cells 24 h after lurbinectedin treatment. Here, BCL2 is linked to small cell lung carcinoma.